Pluspunten
-clinical research that puts patients first -strong infrastructure -learning opportunities -good benefits -emphasis on D&I in all facets of business -on campus gym and access to bay trail
Minpunten
-no/low amount of promotions for non science role -new leadership is changing the culture and don’t seem open to any ideas from the long time employees that made Genentech great and had no power over leader decisions or failed molecules -return to office is more strict than pre-COVID -huge budget constraints that limit our ability to engage with sites or attend development conferences for operations staff -departments has vastly different and unequal “perks” including seemingly unlimited travel for some groups and little to none for others -staff is over worked with high performers taking a much larger share of workload without being compensated via yearly performance bonus -there’s been quite a bit of attrition without rehiring -morale is low -no stock purchase options and stock awarded with compensation package has been under performing for years